Jump to navigation Jump to search
External IDsGeneCards: [1]
RefSeq (mRNA)



RefSeq (protein)



Location (UCSC)n/an/a
PubMed searchn/an/a
View/Edit Human

Potassium voltage-gated channel, Shab-related subfamily, member 1, also known as KCNB1 or Kv2.1, is a protein that, in humans, is encoded by the KCNB1 gene.[1][2][3]

Potassium voltage-gated channel subfamily B member one, or simply known as KCNB1, is a delayed rectifier and voltage-gated potassium channel found throughout the body. The channel has a diverse number of functions. However, its main function, as a delayed rectifier, is to propagate current in its respective location. It is commonly expressed in the central nervous system, but may also be found in pulmonary arteries, auditory outer hair cells, stem cells, the retina, and organs such as the heart and pancreas. Modulation of K+ channel activity and expression has been found to be at the crux of many profound pathophysiological disorders in several cell types.[4]

Potassium channels are among the most diverse of all ion channels in eukaryotes. With over 100 genes coding numerous functions, many isoforms of potassium channels are present in the body, but most are divided up into two main groups: inactivating transient channels and non-inactivating delayed rectifiers. Due to the multiple varied forms, potassium delayed rectifier channels open or close in response to a myriad of signals. These include: cell depolarization or hyperpolarization, increases in intracellular calcium concentrations, neurotransmitter binding, or second messenger activity such as G-proteins or kinases.[5]


The general structure of all potassium channels contain a centered pore composed of alpha subunits with a pore loop expressed by a segment of conserved DNA, T/SxxTxGxG. This general sequence comprises the selectivity of the potassium channel. Depending on the channel, the alpha subunits are constructed in either a homo- or hetero-association, creating a 4-subunit selectivity pore or a 2-subunit pore, each with accessory beta subunits attached intracellularly. Also on the cytoplasmic side are the N- and C- termini, which play a crucial role in activating and deactivating KCNB1 channels. This pore creates the main opening of the channel where potassium ions flow through.[6]

The type of pore domain (number of subunits) determines if the channel has the typical 6 transmembrane (protein) spanning regions, or the less dominant inward rectifier type of only 2 regions. KCNB1 has 6TM labeled S1-S6, each with a tetrameric structure. S5 and S6 create the p-loop, while S4 is the location of the voltage sensor. S4, along with S2 and S3 create the ‘activating’ portions of the delayed rectifier channel.[6] The heteromeric complexes that contain the distinct pore are electrically inactive or non-conducting, but unlike other potassium families, the pore of the KCNB1 group has numerous phosphorylation sites allowing kinase activity. Maturing KCNB1 channels develop these phosphorylation sites within the channel pore, but lack a glycosylation stage in the N-terminus.[7]

Specifically, the KCNB1 delayed rectifier channel conducts a potassium current (K+). This mediates high frequency firing due to the phosphorylation sites located within the channel via kinases and a major calcium influx typical of all neurons.[7]


The kinetics surrounding the activation and deactivation of the KCNB1 channel is relatively unknown, and has been under considerable study. Three of the six transmembrane regions, S2, S3 and S4, contribute to the activation phase of the channel. Upon depolarization, the S4 region, which is positively charged, is moved in response to the subsequent positive charge of the depolarization. As a result of S4 movement, the negatively charged regions of S2 and S3 appear to move as well.[6] The movement of these regions causes an opening of the channel gate within regions of S5 and S6.[8] The intracellular regions of the C and N-terminus also play a crucial role in the activation kinetics of the channel. The two termini interact with one other, as the C-terminus folds around the N-terminus during channel activation. The relative movement between the N- and C- termini greatly aids in producing a conformational change of the channel necessary for channel opening. This interaction between these intracellular regions is believed to be linked with membrane-spanning regions of S1 and S6, and thus aid in the movement of S2, S3, and S4 in opening the channel.[6][8] Studies on selective mutations knocking out these intracellular termini have been shown to produce larger reductions in speed and probability of channel opening, which indicates their importance in channel activation.[6]


Voltage-gated potassium (Kv) channels represent the most complex class of voltage-gated ion channels from both functional and structural standpoints.[1] Delayed rectifier potassium channels’ most prevalent role is in the falling phase of physiological action potentials. KCNB1 rectifiers are also important in forming the cardiac beat and rate synchronicity that exists within the heart, and the lysis of target molecules in the immune response. These channels can also act as effectors in downstream signaling in G-protein coupled receptor transduction. KCNB1’s regulation and propagation of current provides a means for regulatory control over several physiological functions.[5] Their diverse functions include regulating neurotransmitter release, heart rate, insulin secretion, neuronal excitability, epithelial electrolyte transport, smooth muscle contraction, and apoptosis.[1]

Voltage-gated potassium channels are essential in regulating neuronal membrane potential, and in contributing to action potential production and firing.[9] In mammalian CNS neurons, KCNB1 is a predominant delayed rectifier potassium current that regulates neuronal excitability, action potential duration, and tonic spiking. This is necessary when it comes to proper neurotransmitter release, as such release is dependent on membrane potential. In mouse cardiomyocytes, KCNB1 channel is the molecular substrate of major repolarization current IK-slow2. Transgenic mice, expressing a dominant-negative isoform of KCNB1, exhibit markedly prolonged action potentials and demonstrate arrhythmia.[10] KCNB1 also contributes to the function and regulation of smooth muscle fibers. Human studies on pulmonary arteries have shown that normal, physiological inhibition of KCNB1 current aids vasoconstriction of arteries.[11] In human pancreatic ß cells, KCNB1, which mediates potassium efflux, produces a downstroke of the action potential in the cell.[12] In effect, this behavior halts insulin secretion, as its activation decreases the Cav channel-mediated calcium influx that is necessary for insulin exocytosis. KCNB1 has also been found to promote apoptosis within neuronal cells. It is currently believed that KCNB1-induced apoptosis occurs in response to an increase in reactive oxygen species (ROS) that results either from acute oxidation or as a consequence of other cellular stresses.[7]


KCNB1 conductance is regulated primarily by oligomerization and phosphorylation. Additional forms of regulation include SUMOylation and acetylation, although the direct effect of these modifications is still under investigation. KCNB1 consensus sites in the N-terminus are not subject to glycosylation.[4]


Many proteins undergo phosphorylation, or the addition of phosphate groups to amino acids subunits. Phosphorylation is modulated by kinases, which add phosphate groups, and phosphatases, which remove phosphate groups. In its phosphorylated state, KCNB1 is a poor conductor of current. There are 16 phosphorylation sites that are subject to the activity of kinases, such as cyclin-dependent kinase 5 and AMP-activated protein kinase. These sites are reversibly regulated by phosphatases such as, phosphatase calcineurin. Under periods of high electrical activity, depolarization of the neuron increases calcium influx and triggers phosphatase activity. Under resting conditions, KCNB1 tends to be phosphorylated. Phosphorylation raises the threshold voltage requirement for activation and allows microdomains to bind the channel, preventing KCNB1 from entering the plasma membrane. Microdomains localize KCNB1 in dendrites in cell bodies of hippocampal and cortical neurons. Conductance associated with de-phosphorylation of this channel acts to decrease or end periods high excitability. However, this relationship is not static and is cell dependent. The role of phosphorylation can be affected by reactive oxygen species (ROS) that increase during oxidative stress. ROS act to increase the levels of zinc (Zn2+) and calcium (Ca2+) intracellularly that act with protein kinases to phosphorylate certain sites on KCNB1. This phosphorylation increases the insertion of KCNB1 into the membrane and elevates conductance. Under these conditions the interaction with SNARE protein syntaxin, is enhanced. This surge of KCNB1 current induces activation of a pro-apoptotic pathway, DNA fragmentation, and caspase activation.[4]


Another proposed mechanism for regulation of apoptosis is oligomerization, or the process of forming multi-protein complexes held together through disulfide bonds. Under oxidative stress, reactive oxygen species (ROS) form and act to regulate KCNB1 through oxidation. Increase in oxygen radicals directly causes formation of KCNB1 oligomers that then accumulate in the plasma membrane and initially decrease current flow [13][14]. Oligomer activation of c-Src and JNK kinases induces the initial pro-apoptotic signal, which is coupled to KCNB1 current. This further promotes the apoptosis pathway [15]. KCNB1 oligomers have been detected in the post mortem human hippocampus [16]


Potassium delayed rectifiers have been implicated in many pharmacological uses in the investigation of biological toxins for drug development. A main component to many of the toxins with negative effects on delayed rectifiers contain cystine inhibitors that are arranged around disulfide bond formations. Many of these toxins originate from species of tarantulas. G. spatulata produces the hanatoxin, which was the first drug to be manipulated to interact with KCNB1 receptors by inhibiting the activation of most potassium voltage-gated channels. Other toxins, such as stromatoxin, heteroscordratoxin, and guangxitoxin, target the selectivity of voltage KCNB1 rectifiers, by either lowering potassium binding affinity or increasing the binding rate of potassium. This can lead to excitotoxicity, or overstimulation of postsynaptic neurons. In nature, the prey of tarantula that are injected with these endogenous toxins induces this excitotoxic effect, producing paralysis for easy capture. Physiologically, these venoms work on KCNB1 rectifier affinity by altering the channels’ voltage sensor, making it more or less sensitive to extracellular potassium concentrations.[17] KCNB1 is also susceptible to tetraethylammonium (TEA) and 4-aminopyridine (4-AP), which completely block all channel activity. TEA also works on calcium-activated potassium channels, furthering its inhibitory effects on neurons and skeletal muscle. Some isoforms of TEA are beneficial for patients with severe Alzheimer’s, as blocking KCNB1 channels reduces the amount of neuronal apoptosis, thereby slowing the rate of dementia.[18] This has been attributed to the oxidative properties of the channel by ROS.[5]

Physiological Role in Disease

Neurodegenerative Disease

Oxidative damage is widely considered to play a role in neurodegenerative disorders, including Alzheimers disease. Such oxidative stress alters the redox sensitivity of the Kv2.1 delayed rectifier, resulting in the modulation of the channel.[4] In vitro studies and studies in animal models show that when KCNB1 is oxidized, it no longer conducts, leading to neurons becoming hyperpolarized and dying; oxidized KCNB1 also clusters in lipid rafts and cannot be internalized, which also leads to apoptosis. These alterations disrupt normal neuronal signaling and increase the likelihood of neurological diseases. Oxidized (oligomerized) KCNB1 channels are present in the hippocampi of old (Braak stage 1-2) and Alzheimer's disease (Braak stage 5) donors of either sexes [19] [20]

Increased probability of the channel remaining open can also potentially drive neurodegeneration. Human immunodeficiency virus type-1 (HIV-1)-associated dementia (HAD) may be driven by an overabundance of glutamate, which in turn can trigger increased calcium levels, which in turn can drive calcium-dependent dephosphorylation of KCNB1 channels, which increases probability of channel activation and current conductance. Enhanced KCNB1 current couples cell shrinkage associated with apoptosis and dendritic beading leading to diminished long term potentiation. These neuronal modifications may explain the atrophy of cell layer volume and late stage cell death observed in HAD disease.[21]


Exploitation of this channel is advantageous in cancer cell survival as they have the ability to produce heme oxygenase-1, an enzyme with the ability to generate carbon monoxide (CO). Oncogenic cells benefit from producing CO due to the antagonizing effects of the KCNB1 channel. Inhibition of KCNB1 allows cancer proliferation without the apoptotic pathway preventing tumor formation. Although potassium channels are studied as a therapeutic target for cancer, this apoptotic regulation is dependent on cancer type, potassium channel type, expression levels, intracellular localization as well as regulation by pro- or anti-apoptotic factors. [22]


KCNB1 has been shown to interact with:

See also


  1. 1.0 1.1 1.2 "Entrez Gene: KCNB1 potassium voltage-gated channel, Shab-related subfamily, member 1".
  2. Melis R, Stauffer D, Zhao X, Zhu XL, Albrecht B, Pongs O, Brothman A, Leppert M (January 1995). "Physical and genetic localization of a Shab subfamily potassium channel (KCNB1) gene to chromosomal region 20q13.2". Genomics. 25 (1): 285–7. doi:10.1016/0888-7543(95)80138-C. PMID 7774931.
  3. Gutman GA, Chandy KG, Grissmer S, Lazdunski M, McKinnon D, Pardo LA, Robertson GA, Rudy B, Sanguinetti MC, Stühmer W, Wang X (December 2005). "International Union of Pharmacology. LIII. Nomenclature and molecular relationships of voltage-gated potassium channels". Pharmacological Reviews. 57 (4): 473–508. doi:10.1124/pr.57.4.10. PMID 16382104.
  4. 4.0 4.1 4.2 4.3 Shah NH, Aizenman E (February 2014). "Voltage-gated potassium channels at the crossroads of neuronal function, ischemic tolerance, and neurodegeneration". Translational Stroke Research. 5 (1): 38–58. doi:10.1007/s12975-013-0297-7. PMC 3946373. PMID 24323720.
  5. 5.0 5.1 5.2 "Potassium channel, voltage-dependent, beta subunit, KCNAB1 (IPR005400)". InterPro. EMBL-EBI. Retrieved 2017-04-04.
  6. 6.0 6.1 6.2 6.3 6.4 Wray D (May 2004). "The roles of intracellular regions in the activation of voltage-dependent potassium channels". European Biophysics Journal. 33 (3): 194–200. doi:10.1007/s00249-003-0363-2. PMID 14608450.
  7. 7.0 7.1 7.2 Patel R, Sesti F (May 2016). "Oxidation of ion channels in the aging nervous system". Brain Research. 1639: 174–85. doi:10.1016/j.brainres.2016.02.046. PMID 26947620.
  8. 8.0 8.1 Wray D (March 2009). "Intracellular regions of potassium channels: Kv2.1 and heag". European Biophysics Journal. 38 (3): 285–92. doi:10.1007/s00249-008-0354-4. PMID 18607586.
  9. Sesti F (March 2016). "Oxidation of K(+) Channels in Aging and Neurodegeneration". Aging and Disease. 7 (2): 130–5. doi:10.14336/AD.2015.0901. PMC 4809605. PMID 27114846.
  10. Murakoshi H, Trimmer JS (March 1999). "Identification of the Kv2.1 K+ channel as a major component of the delayed rectifier K+ current in rat hippocampal neurons" (PDF). The Journal of Neuroscience. 19 (5): 1728–35. PMID 10024359.
  11. Joseph BK, Thakali KM, Moore CL, Rhee SW (April 2013). "Ion channel remodeling in vascular smooth muscle during hypertension: Implications for novel therapeutic approaches". Pharmacological Research. 70 (1): 126–38. doi:10.1016/j.phrs.2013.01.008. PMC 3607210. PMID 23376354.
  12. Yang SN, Shi Y, Yang G, Li Y, Yu J, Berggren PO (November 2014). "Ionic mechanisms in pancreatic β cell signaling". Cellular and Molecular Life Sciences. 71 (21): 4149–77. doi:10.1007/s00018-014-1680-6. PMID 25052376.
  13. Wu X, Hernandez-Enriquez B, Banas M, Xu R, Sesti F (2013). "Molecular mechanisms underlying the apoptotic effect of KCNB1 K+ channel oxidation". J Biol Chem. 288 (6): 4128–4134. doi:10.1074/jbc.M112.440933. PMC 3567663.
  14. Cotella D, Hernandez B, Wu X, Li R, Pan Z, Leveille J, Link CD, Oddo S, Sesti F (2012). "Toxic role of K+ channel oxidation in mammalian brain". J. Neurosci. 32 (12): 4133–4144. doi:10.1523/JNEUROSCI.6153-11.2012.
  15. Yu W, Gowda M, Singh S, Sesti F (2017). "Oxidation of KCNB1 potassium channels triggers apoptotic integrin signaling in the brain". Cell Death Dis. 8 (4): e2737. doi:10.1038/cddis.2017.160.
  16. Wei Y, Shih R, Sesti F (2018). "Oxidation of KCNB1 channels in the human brain and in mouse model of Alzheimer's disease". Cell Death Dis. 9 (820). doi:10.1038/s41419-018-0886-1.
  17. Swartz KJ (February 2007). "Tarantula toxins interacting with voltage sensors in potassium channels". Toxicon. 49 (2): 213–30. doi:10.1016/j.toxicon.2006.09.024. PMC 1839852. PMID 17097703.
  18. Quinn CC, Begenisich T (2017-04-12). "Pharmacology and surface electrostatics of the K channel outer pore vestibule". The Journal of Membrane Biology. 212 (1): 51–60. doi:10.1007/s00232-006-0039-9. PMC 1784061. PMID 17206516.
  19. Wei Y, Shih R, Sesti F (2018). "Oxidation of KCNB1 channels in the human brain and in mouse model of Alzheimer's disease". Cell Death Dis. 9 (820). doi:10.1038/s41419-018-0886-1.
  20. Peers C, Boyle JP (February 2015). "Oxidative modulation of K+ channels in the central nervous system in neurodegenerative diseases and aging". Antioxidants & Redox Signaling. 22 (6): 505–21. doi:10.1089/ars.2014.6007. PMID 25333910.
  21. Keblesh J, Hu D, Xiong H (March 2009). "Voltage-gated potassium channels in human immunodeficiency virus type-1 (HIV-1)-associated neurocognitive disorders". Journal of Neuroimmune Pharmacology. 4 (1): 60–70. doi:10.1007/s11481-008-9106-6. PMC 3974578. PMID 18459047.
  22. Kondratskyi A, Kondratska K, Skryma R, Prevarskaya N (October 2015). "Ion channels in the regulation of apoptosis". Biochimica et Biophysica Acta. Membrane Channels and Transporters in Cancers. 1848 (10 Pt B): 2532–46. doi:10.1016/j.bbamem.2014.10.030. PMID 25450339.
  23. Ottschytsch N, Raes A, Van Hoorick D, Snyders DJ (June 2002). "Obligatory heterotetramerization of three previously uncharacterized Kv channel alpha-subunits identified in the human genome". Proceedings of the National Academy of Sciences of the United States of America. 99 (12): 7986–91. doi:10.1073/pnas.122617999. PMC 123007. PMID 12060745.
  24. Peretz A, Gil-Henn H, Sobko A, Shinder V, Attali B, Elson A (August 2000). "Hypomyelination and increased activity of voltage-gated K(+) channels in mice lacking protein tyrosine phosphatase epsilon". The EMBO Journal. 19 (15): 4036–45. doi:10.1093/emboj/19.15.4036. PMC 306594. PMID 10921884.

Further reading

External links

This article incorporates text from the United States National Library of Medicine, which is in the public domain.